Domestic pharmaceutical industry is at risk

Published: 2002-10-14 07:00:00

Updated: 2002-10-14 07:00:00

Amid the domestic pharmaceutical industry's concerns over the repeated cuts in insurance drug prices following the government ex post facto drug management, the new reimbursement price re-evaluation system aiming at reducing the current drug prices will be implemented from this December, thus it ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK